Enriched Pathway | Zone 1 | Zone 2 | Zone 3 | Zone 4 |
---|---|---|---|---|
Signal transduction | 43% | 21.6% | - | - |
Immune system | 32% | 10.9% | 5.4% | - |
MAPK signalling | 25.8% | 2.3% | - | - |
Pathway in cancer | 20.7% | 3.5% | - | - |
Disease | 22.6% | 9.3% | 5.4% | - |
Hemostasis | 15.9% | 5.3% | - | - |
Cell Cycle | 5.4% | 5.5% | 3.1% | - |
Gene expression | 7.8% | 8.3% | 12.5% | - |
Metabolism | 13.1% | 9.3% | 8.8% | 15.9% |